Conference abstract · 21 May 2018
Conference abstractPublished 2018
Non-invasive delivery of magnetic drug nanocarrier to the brain
Florida International University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Advancements in nanobiotechnology revolutionized health care management via investigating nanomedicine and delivery for targeted diseases. Due to easy tunable performance features these systems serves in a controlled manner and significantly useful for personalized health care. Keeping this in view, magnetically-guided brain delivery of magneto-electro nanoparticles (MENPs±25 nm), a drug nanocarriers capable to exhibit AC magnetic field stimuli responsive on-demand drug release, in C57Bl/J mice has been demonstrated. Our findings confirm uniform distribution of MENPs in the brain of mice without causing clinical toxicity and altering neurologic behavior. However, the translation of this brain delivery method for humans is not yet developed due to a mismatch of available static magnet dimension in relation to the human brain size and shape. Aiming to develop personalized nanomedicine to eradicate neuro-HIV/AIDS, we demonstrated magnetically-guided brain delivery of MENPs to the brain of an adult female baboon (Papio hamadryas) using Magnetic Resonance Imaging (MRI) as a navigation tool. An optimized dose of MENP (22 mg/13 kg) suspended in 100 ml PBS was injected into the baboon vasculature via the saphenous vein with a flow rate of 220 ml/hr. After injection, the baboon was placed under static MRI magnetic exposure for 3 hours to achieve magnetically-guided brain delivery. MRI image analysis confirmed MENPs distribution within the brain regions such as basal ganglia, hemisphere and vertex. The results of histopathology and blood toxicity profile studies confirmed that injected MENPs did not cause any toxicity or metabolic abnormalities. We propose utilizing MRI as a potential navigation tool for the brain delivery of magnetic therapeutic formulations to treat brain diseases for personalized health care.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 2020
Non-Invasive Strategies for Nose-to-Brain Drug Delivery
Conference abstract
Surface modified lipid nanocarriers for non-invasive oral delivery of biomacromolecule
Short communication · 28 Dec 2023
Non-Invasive Drug Delivery: Advantages and Applications of Transdermal and Topical Systems
Opinion · 28 Apr 2023
Emerging Technologies for Non-Invasive Drug Delivery: From Inhalation to Implants
More from this journal
The newest in Journal of Pharmaceutics & Drug Delivery Research.
Research article · 12 Jun 2025
Melt-in-Mouth Miracles: A New Era of Drug Delivery with Mouth Dissolving Tablets
Research article · 20 Feb 2025
Sustained Drug Delivery in Pharmaceutical Dosage Forms for Novel Approaches of Formulation Design
Research article · 23 Jan 2025
Cutting Out Counterfeits: How Blockchain Can Revolutionize Drug Traceability?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutics & Drug Delivery Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ajeet Kumar Kaushik”
- BylineArticles whose byline prints “Madhavan Nair”

